Boston, MA -- (SBWIRE) -- 10/25/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Petrotech Oil & Gas Inc(OTCMKTS:PTOG), Micron Technology, Inc.(NASDAQ:MU), Dendreon Corporation(NASDAQ:DNDN), Generex Biotechnology Corporation(OTCMKTS:GNBT)
Petrotech Oil & Gas Inc(OTCMKTS:PTOG) opened its shares at the price of $0.01 for the day. Its closing price was $0.0105 after losing -11.02% for the day. The company traded with the total volume of 20.19 million shares, while its average trading volume remained 1.35 million shares. The beta of PTOG stands at 1.73. Petrotech Oil and Gas, Inc. initiates, operates, and develops enhanced oil recovery opportunities within qualifying oil reservoirs in the United States.
Has PTOG Found The Bottom and Ready To Move Up? Find Out Here
Micron Technology, Inc.(NASDAQ:MU) percentage change surged +1.69% to close at $16.83 with the total traded volume of 30.29 million shares, and average volume of 50.76 million. The 52 week range of the stock remained $5.16 - $18.85, while its day lowest price was $16.40 and it hit its day highest price at $16.92. Micron Technology, Inc., together with its subsidiaries, engages in manufacturing and marketing semiconductor devices worldwide.
For How Long MU’s Gloss will Attract Investors ? Find out via this report
Dendreon Corporation(NASDAQ:DNDN) started its trading session with the price of $2.37 and closed at $2.41 by scoring +7.11%. DNDN’s stocks traded with total volume of 6.33 million shares, while the average trading volume remained 4.36 million shares. The beta of DNDN stands at 4.13. Day range of the stock was $2.24 -$2.41. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients.
Will DNDN Continue To Move Higher? Find Out Here
Generex Biotechnology Corporation(OTCMKTS:GNBT) ended its day with the gain of +4.92% and closed at the price of $0.0320 after opening at $0.03. Stock traded during its last trading session with the total volume of 2.61 million shares, as compared to its average volume of 1.95 million shares. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Why Should Investors Buy GNBT After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)